177 related articles for article (PubMed ID: 25584911)
21. Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.
Lumry W; Manning ME; Hurewitz DS; Davis-Lorton M; Fitts D; Kalfus IN; Uknis ME
J Pediatr; 2013 May; 162(5):1017-22.e1-2. PubMed ID: 23312695
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.
Hofstra JJ; Kleine Budde I; van Twuyver E; Choi G; Levi M; Leebeek FW; de Monchy JG; Ypma PF; Keizer RJ; Huitema AD; Strengers PF
Clin Immunol; 2012 Mar; 142(3):280-90. PubMed ID: 22197071
[TBL] [Abstract][Full Text] [Related]
23. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA
J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404
[TBL] [Abstract][Full Text] [Related]
24. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
Riedl MA; Bygum A; Lumry W; Magerl M; Bernstein JA; Busse P; Craig T; Frank MM; Edelman J; Williams-Herman D; Feuersenger H; Rojavin M;
J Allergy Clin Immunol Pract; 2016; 4(5):963-71. PubMed ID: 27286778
[TBL] [Abstract][Full Text] [Related]
25. Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2).
Krassilnikova S; Craig ET; Craig TJ
Expert Rev Clin Immunol; 2010 May; 6(3):327-34. PubMed ID: 20441418
[TBL] [Abstract][Full Text] [Related]
26. C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk.
Schürmann D; Herzog E; Raquet E; Nolte MW; May F; Müller-Cohrs J; Björkqvist J; Dickneite G; Pragst I
Thromb Haemost; 2014 Nov; 112(5):960-71. PubMed ID: 25103795
[TBL] [Abstract][Full Text] [Related]
27. Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.
Farkas H; Varga L; Moldovan D; Obtulowicz K; Shirov T; Machnig T; Feuersenger H; Edelman J; Williams-Herman D; Rojavin M
Ann Allergy Asthma Immunol; 2016 Nov; 117(5):508-513. PubMed ID: 27788880
[TBL] [Abstract][Full Text] [Related]
28. The effect of weight on the efficacy and safety of C1 esterase inhibitor concentrate for the treatment of acute hereditary angioedema.
Bernstein JA; Machnig T; Keinecke HO; Whelan GJ; Craig TJ
Clin Ther; 2014 Apr; 36(4):518-25. PubMed ID: 24661784
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.
Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR
Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057
[TBL] [Abstract][Full Text] [Related]
30. Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency.
Moldovan D; Bernstein JA; Cicardi M
Immunotherapy; 2015; 7(7):739-52. PubMed ID: 26250409
[TBL] [Abstract][Full Text] [Related]
31. Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.
Fox J; Vegh AB; Martinez-Saguer I; Wuillemin WA; Edelman J; Williams-Herman D; Rojavin M; Rosenberg T
Allergy Asthma Proc; 2017 May; 38(3):216-221. PubMed ID: 28441992
[TBL] [Abstract][Full Text] [Related]
32. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database.
Gandhi PK; Gentry WM; Bottorff MB
Pharmacotherapy; 2012 Oct; 32(10):902-9. PubMed ID: 23033229
[TBL] [Abstract][Full Text] [Related]
33. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
Riedl M
Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
[TBL] [Abstract][Full Text] [Related]
34. Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review.
Brooks JP; Radojicic C; Riedl MA; Newcomer SD; Banerji A; Hsu FI
J Allergy Clin Immunol Pract; 2020 Jun; 8(6):1875-1880.e3. PubMed ID: 32251736
[TBL] [Abstract][Full Text] [Related]
35. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
[TBL] [Abstract][Full Text] [Related]
36. Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.
Jurado-Palomo J; Muñoz-Caro JM; López-Serrano MC; Prior N; Cabañas R; Pedrosa M; Burgueño M; Caballero T
J Investig Allergol Clin Immunol; 2013; 23(1):1-6. PubMed ID: 23653967
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
Wasserman RL; Levy RJ; Bewtra AK; Hurewitz D; Craig TJ; Kiessling PC; Keinecke HO; Bernstein JA
Ann Allergy Asthma Immunol; 2011 Jan; 106(1):62-8. PubMed ID: 21195947
[TBL] [Abstract][Full Text] [Related]
38. Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.
Baker JW; Craig TJ; Riedl MA; Banerji A; Fitts D; Kalfus IN; Uknis ME
Allergy Asthma Proc; 2013; 34(2):162-9. PubMed ID: 23484892
[TBL] [Abstract][Full Text] [Related]
39. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
40. C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
Bewtra AK; Levy RJ; Jacobson KW; Wasserman RL; Machnig T; Craig TJ
Allergy Asthma Proc; 2012; 33(5):427-31. PubMed ID: 23026185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
